Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham consumer health care profit margins nearing 20% goal -- Leschley.

This article was originally published in The Tan Sheet

Executive Summary

SMITHKLINE CONSUMER HEALTH CARE PROFIT MARGINS NEARING 20% GOAL, SmithKline Beecham CEO Jan Leschley noted at an April 16 "New Ventures in Health Care" conference at the Wharton School. The company's trading profit margin for the consumer health care sector was 16.7% in 1997, up .9% from the year before. While "it is not the [27%] margin that you have" in the pharmaceutical sector, Leschley acknowledged, it is "getting closer and closer to 20%, which is our goal."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel